Form 4 for PALI PALISADE BIO, INC.
Accepted 2022-05-02 00:00:00 ET · period of report 2022-04-29 · accession 0001209191-22-026450 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-05-02 | 2022-04-29 | PALI | Finley John David | CFO | J - Other | $0.00 | +12.5K | 38.9K | +48% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-29 | J | A | 12,545 | $0.00 | 38,867 | I By FCW Investments LLC | — | — | (F1) Represents a distribution of partnership assets (shares of Palisade Bio, Inc. common stock) made by LBS Investors LP to its partners in connection with the partnership's dissolution. No additional payment is being made by any of the partners in connection with the distribution. (F2) The Reporting Person is the managing member of FCW Investments LLC and has sole investment and voting power over the securities held by this entity. |